Optimising antiplatelet therapy in acute coronary syndromes

Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 12

Abstract

Platelet mediated thrombosis plays central role in pathogenesis of acute coronary syndromes (ACS). The main receptors acting in this process: P2Y12 and GPIIb/IIIa, are major targets of pharmacotherapy. Inhibition of another platelet receptor PAR-1 is under investigation. Addition of clopidogrel, P2Y12 inhibitor, to aspirin (ASA) reduces major adverse cardiovascular events in wide range of patients, but there is a group of hyporesponders with high on treatment platelet reactivity and worse thrombotic outcomes, and also hyperresponders with higher bleeding risk. These groups might be identified not only by clinical factors, but also genetic tests and platelet reactivity assays. Antiplatelet therapy may be optimized by using higher doses of clopidogrel, or new more potent P2Y12 inhibitors: prasugrel, ticagrelor and elinogrel. Triple antiplatelet therapy including GPIIb/IIIa inhibitors: abciximab, tirofiban or eptifibatide, is recommended in ACS patients determined to be at elevated risk for ischemic events, but optimal timing of therapy and selection of GPIIb/IIIa inhibitor is still discussed. The challenge of future ACS pharmacotherapy is to find optimal window of platelet inhibition, balanced between efficacy and safety with tailored dual or triple antiplatelet therapy.

Authors and Affiliations

Bogumił Ramotowski, Andrzej Budaj

Keywords

Related Articles

Zakażenia układu oddechowego u ciężarnych

Układ oddechowy ciężarnej podlega szeregowi zmian w trakcie rozwoju ciąży. Zakażenia układu oddechowego stanowią najczęstszą przyczynę porad ambulatoryjnych, stanowiąc ponad 50% wszystkich zakażeń pozaszpitalnych. Zakaże...

Token system as an intervention used for reducing hyperactivity in children with ADHD

The aim of the experiment was to study the effects of a token system on the level of hyperactivity in three children age 8-9 years, diagnosed with the Attention Deficit Hyperactivity Disorder (ADHD). The study was conduc...

The effect of hyperaldosteronism on the cardiovascular system

Hyperaldosteronism causes arterial hypertension, fibrosis and hypertrophy of blood vessel muscles and myocardium, is proinflamatory and prothrombothic state and decreases endothelium function.<br>Patients w...

Udar w wieku podeszłym – odmienności

Systematyczne starzenie się społeczeństwa powoduje zwiększenie częstości występowania udaru mózgu, szczególnie w najstarszej grupie wiekowej. W przeciągu następnych 20 lat przewiduje się zwiększenie zachorowalności na ud...

Nonalcoholic fatty liver disease in patients with morbid obesity

<b>Introduction. </b>Accumulation of fat in obese individuals can impact hepatocytes and contributes to the inflammatory process, which in extreme cases results in fibrosis, cirrhosis, and fai...

Download PDF file
  • EP ID EP53809
  • DOI -
  • Views 188
  • Downloads 0

How To Cite

Bogumił Ramotowski, Andrzej Budaj (2010). Optimising antiplatelet therapy in acute coronary syndromes. Postępy Nauk Medycznych, 23(12), -. https://www.europub.co.uk/articles/-A-53809